BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31241916)

  • 1. Parallel-Reaction-Monitoring-Based Proteome-Wide Profiling of Differential Kinase Protein Expression during Prostate Cancer Metastasis in Vitro.
    Miao W; Yuan J; Li L; Wang Y
    Anal Chem; 2019 Aug; 91(15):9893-9900. PubMed ID: 31241916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Quantitative Kinome Analysis Identifies PRPS2 as a Promoter for Colorectal Cancer Metastasis.
    Miao W; Wang Y
    J Proteome Res; 2019 May; 18(5):2279-2286. PubMed ID: 30908912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Kinase Expression Related to Increased Migration of PC-3M Cells Using Global Comparative Phosphoproteome Analysis.
    Gao Y; Ha YS; Kwon TG; Cho YC; Lee S; Lee JN
    Cancer Genomics Proteomics; 2020; 17(5):543-553. PubMed ID: 32859632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of human prostate cancer PC-3M-1E8 cells and PC-3M-2B4 cells of same origin but with different metastatic potential.
    Zhang S; Zheng C; Yao S; Wang Z; Xu L; Yang R; Meng X; Wu J; Zhou L; Sun Z
    PLoS One; 2018; 13(10):e0206139. PubMed ID: 30379883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
    Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
    Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.
    Yan Y; Zhou B; Qian C; Vasquez A; Kamra M; Chatterjee A; Lee YJ; Yuan X; Ellis L; Di Vizio D; Posadas EM; Kyprianou N; Knudsen BS; Shah K; Murali R; Gertych A; You S; Freeman MR; Yang W
    Nat Commun; 2022 Feb; 13(1):669. PubMed ID: 35115556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maclurin exerts anti-cancer effects on PC3 human prostate cancer cells via activation of p38 and inhibitions of JNK, FAK, AKT, and c-Myc signaling pathways.
    Lee YJ; Jung O; Lee J; Son J; Cho JY; Ryou C; Lee SY
    Nutr Res; 2018 Oct; 58():62-71. PubMed ID: 30340816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Targeted Quantitative Proteomic Method Revealed a Substantial Reprogramming of Kinome during Melanoma Metastasis.
    Miao W; Li L; Liu X; Qi TF; Guo L; Huang M; Wang Y
    Sci Rep; 2020 Feb; 10(1):2485. PubMed ID: 32051510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955.
    Bisoffi M; Klima I; Gresko E; Durfee PN; Hines WC; Griffith JK; Studer UE; Thalmann GN
    J Urol; 2004 Sep; 172(3):1145-50. PubMed ID: 15311059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HGK promotes metastatic dissemination in prostate cancer.
    Garcia-Garcia S; Rodrigo-Faus M; Fonseca N; Manzano S; Győrffy B; Ocaña A; Bragado P; Porras A; Gutierrez-Uzquiza A
    Sci Rep; 2021 Jun; 11(1):12287. PubMed ID: 34112843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell fate regulation by reticulon-4 in human prostate cancers.
    Zhao H; Su W; Zhu C; Zeng T; Yang S; Wu W; Wang D
    J Cell Physiol; 2019 Jul; 234(7):10372-10385. PubMed ID: 30480803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RBM4-SRSF3-MAP4K4 splicing cascade modulates the metastatic signature of colorectal cancer cell.
    Lin JC; Lee YC; Tan TH; Liang YC; Chuang HC; Fann YC; Johnson KR; Lin YJ
    Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):259-272. PubMed ID: 29138007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways.
    Wang Z; Li Y; Banerjee S; Kong D; Ahmad A; Nogueira V; Hay N; Sarkar FH
    J Cell Biochem; 2010 Mar; 109(4):726-36. PubMed ID: 20052673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.
    Majumder PK; Febbo PG; Bikoff R; Berger R; Xue Q; McMahon LM; Manola J; Brugarolas J; McDonnell TJ; Golub TR; Loda M; Lane HA; Sellers WR
    Nat Med; 2004 Jun; 10(6):594-601. PubMed ID: 15156201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional screen identifies kinases driving prostate cancer visceral and bone metastasis.
    Faltermeier CM; Drake JM; Clark PM; Smith BA; Zong Y; Volpe C; Mathis C; Morrissey C; Castor B; Huang J; Witte ON
    Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E172-81. PubMed ID: 26621741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.
    Kim SJ; Johnson M; Koterba K; Herynk MH; Uehara H; Gallick GE
    Clin Cancer Res; 2003 Nov; 9(14):5161-70. PubMed ID: 14613995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.
    Xu L; Chen S; Bergan RC
    Oncogene; 2006 May; 25(21):2987-98. PubMed ID: 16407830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation.
    Wei J; Xu G; Wu M; Zhang Y; Li Q; Liu P; Zhu T; Song A; Zhao L; Han Z; Chen G; Wang S; Meng L; Zhou J; Lu Y; Wang S; Ma D
    Anticancer Res; 2008; 28(1A):327-34. PubMed ID: 18383865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Secretome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteomics.
    Kwon OK; Jeon JM; Sung E; Na AY; Kim SJ; Lee S
    Cancer Genomics Proteomics; 2018; 15(4):279-290. PubMed ID: 29976633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
    Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.